Waters Corporation Net Income (Loss) Available to Common Stockholders, Diluted
Waters Corporation (WAT) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$136.00 million for the 3-month period ending 2026-07-04, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-08-11
- Waters Corporation net income (loss) available to common stockholders, diluted for the quarter ending 2026-07-04 was -$136.00M, a 192.52% decline year-over-year.
- Waters Corporation net income (loss) available to common stockholders, diluted for the quarter ending 2026-04-04 was -$72.00M, a 159.50% decline year-over-year.
- Waters Corporation net income (loss) available to common stockholders, diluted for the quarter ending 2025-12-31 was $225.21M, a 2.67% decline year-over-year.
- Waters Corporation net income (loss) available to common stockholders, diluted for the quarter ending 2025-09-27 was $148.92M, a 7.79% decline year-over-year.
- Waters Corporation net income (loss) available to common stockholders, diluted for fiscal 2025 was $642.63M, a 0.75% increase from fiscal 2024.
- Waters Corporation net income (loss) available to common stockholders, diluted for fiscal 2024 was $637.83M, a 0.69% decline from fiscal 2023.
- Waters Corporation net income (loss) available to common stockholders, diluted for fiscal 2023 was $642.23M, a 9.26% decline from fiscal 2022.
- Waters Corporation net income (loss) available to common stockholders, diluted for fiscal 2022 was $707.75M, a 2.15% increase from fiscal 2021.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|---|---|
| 2026-07-04 | -$136.00M 10-Q · filed 2026-08-11 | -$208.00M 10-Q · filed 2026-08-11 | $17.21M derived: sum of 3 quarters · filed 2026-08-11 | $166.14M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2026-04-04 | -$72.00M 10-Q · filed 2026-05-12 | $153.21M derived: sum of 2 quarters · filed 2026-05-12 | $302.14M derived: sum of 3 quarters · filed 2026-05-12 | $449.14M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-12-31 | $225.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $374.14M derived: sum of 2 quarters · filed 2026-02-23 | $521.14M derived: sum of 3 quarters · filed 2026-08-11 | $642.63M 10-K · filed 2026-02-23 | ||
| 2025-09-27 | $148.92M 10-Q · filed 2025-11-04 | $295.92M derived: sum of 2 quarters · filed 2026-08-11 | $417.42M 10-Q · filed 2025-11-04 | $648.32M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-06-28 | $147.00M 10-Q · filed 2026-08-11 | $147.11M 10-Q · filed 2025-08-04 | $268.00M 10-Q · filed 2026-08-11 | $268.49M 10-Q · filed 2025-08-04 | $499.40M derived: sum of 3 quarters · filed 2026-08-11 | $660.90M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-29 | $121.00M 10-Q · filed 2026-05-12 | $121.38M 10-Q · filed 2025-05-06 | $352.40M derived: sum of 2 quarters · filed 2026-05-12 | $513.90M derived: sum of 3 quarters · filed 2026-05-12 | $656.64M derived: sum of 4 quarters · filed 2026-05-12 | |
| 2024-12-31 | $231.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $392.90M derived: sum of 2 quarters · filed 2026-02-23 | $535.64M derived: sum of 3 quarters · filed 2026-02-23 | $637.83M 10-K · filed 2026-02-23 | ||
| 2024-09-28 | $161.50M 10-Q · filed 2025-11-04 | $304.24M derived: sum of 2 quarters · filed 2025-11-04 | $406.44M 10-Q · filed 2025-11-04 | $622.64M derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2024-06-29 | $142.74M 10-Q · filed 2025-08-04 | $244.93M 10-Q · filed 2025-08-04 | $461.14M derived: sum of 3 quarters · filed 2026-02-23 | $595.69M derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2024-03-30 | $102.20M 10-Q · filed 2025-05-06 | $318.40M derived: sum of 2 quarters · filed 2026-02-23 | $452.95M derived: sum of 3 quarters · filed 2026-02-23 | $603.51M derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2023-12-31 | $216.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $350.76M derived: sum of 2 quarters · filed 2026-02-23 | $501.31M derived: sum of 3 quarters · filed 2026-02-23 | $642.23M 10-K · filed 2026-02-23 | ||
| 2023-09-30 | $134.55M 10-Q · filed 2024-11-01 | $285.11M derived: sum of 2 quarters · filed 2024-11-01 | $426.03M 10-Q · filed 2024-11-01 | $653.09M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-07-01 | $150.55M 10-Q · filed 2024-07-31 | $291.48M 10-Q · filed 2024-07-31 | $518.54M derived: sum of 3 quarters · filed 2025-02-25 | $674.54M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-04-01 | $140.92M 10-Q · filed 2024-05-07 | $367.99M derived: sum of 2 quarters · filed 2025-02-25 | $523.98M derived: sum of 3 quarters · filed 2025-02-25 | $688.85M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2022-12-31 | $227.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $383.06M derived: sum of 2 quarters · filed 2025-02-25 | $547.92M derived: sum of 3 quarters · filed 2025-02-25 | $707.75M 10-K · filed 2025-02-25 | ||
| 2022-10-01 | $156.00M 10-Q · filed 2023-11-07 | $320.86M derived: sum of 2 quarters · filed 2023-11-07 | $480.69M 10-Q · filed 2023-11-07 | $696.93M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-07-02 | $164.86M 10-Q · filed 2023-08-02 | $324.69M 10-Q · filed 2023-08-02 | $540.93M derived: sum of 3 quarters · filed 2024-02-27 | $702.12M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-04-02 | $159.83M 10-Q · filed 2023-05-09 | $376.07M derived: sum of 2 quarters · filed 2024-02-27 | $537.25M derived: sum of 3 quarters · filed 2024-02-27 | $704.55M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2021-12-31 | $216.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $377.42M derived: sum of 2 quarters · filed 2024-02-27 | $544.72M derived: sum of 3 quarters · filed 2024-02-27 | $692.84M 10-K · filed 2024-02-27 | ||
| 2021-10-02 | $161.19M 10-Q · filed 2022-11-03 | $328.48M derived: sum of 2 quarters · filed 2022-11-03 | $476.60M 10-Q · filed 2022-11-03 | $694.91M derived: sum of 4 quarters · filed 2023-02-27 | ||
| 2021-07-03 | $167.29M 10-Q · filed 2022-08-04 | $315.42M 10-Q · filed 2022-08-04 | $533.73M derived: sum of 3 quarters · filed 2023-02-27 | $660.50M derived: sum of 4 quarters · filed 2023-02-27 | ||
| 2021-04-03 | $148.13M 10-Q · filed 2022-05-05 | $366.44M derived: sum of 2 quarters · filed 2023-02-27 | $493.21M derived: sum of 3 quarters · filed 2023-02-27 | $616.14M derived: sum of 4 quarters · filed 2023-02-27 | ||
| 2020-12-31 | $218.31M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $345.08M derived: sum of 2 quarters · filed 2023-02-27 | $468.01M derived: sum of 3 quarters · filed 2023-02-27 | $521.57M 10-K · filed 2023-02-27 | ||
| 2020-09-26 | $126.77M 10-Q · filed 2021-11-04 | $249.70M derived: sum of 2 quarters · filed 2021-11-04 | $303.26M 10-Q · filed 2021-11-04 | $503.93M derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-06-27 | $122.93M 10-Q · filed 2021-08-05 | $176.49M 10-Q · filed 2021-08-05 | $377.16M derived: sum of 3 quarters · filed 2022-02-24 | $515.29M derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-03-28 | $53.56M 10-Q · filed 2021-05-06 | $254.23M derived: sum of 2 quarters · filed 2022-02-24 | $392.36M derived: sum of 3 quarters · filed 2022-02-24 | $536.77M derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2019-12-31 | $200.67M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $338.80M derived: sum of 2 quarters · filed 2022-02-24 | $483.21M derived: sum of 3 quarters · filed 2022-02-24 | $592.20M 10-K · filed 2022-02-24 | ||
| 2019-09-28 | $138.13M 10-Q · filed 2020-10-28 | $282.54M derived: sum of 2 quarters · filed 2020-10-28 | $391.53M 10-Q · filed 2020-10-28 | $576.68M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2019-06-29 | $144.41M 10-Q · filed 2020-07-29 | $253.40M 10-Q · filed 2020-07-29 | $438.55M derived: sum of 3 quarters · filed 2021-02-24 | $579.56M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2019-03-30 | $108.99M 10-Q · filed 2020-04-29 | $294.14M derived: sum of 2 quarters · filed 2021-02-24 | $435.15M derived: sum of 3 quarters · filed 2021-02-24 | $590.83M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2018-12-31 | $185.15M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $326.17M derived: sum of 2 quarters · filed 2021-02-24 | $481.84M derived: sum of 3 quarters · filed 2021-02-24 | $593.79M 10-K · filed 2021-02-24 | ||
| 2018-09-29 | $141.01M 10-Q · filed 2019-10-30 | $296.69M derived: sum of 2 quarters · filed 2019-10-30 | $408.64M 10-Q · filed 2019-10-30 | $55.47M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-06-30 | $155.68M 10-Q · filed 2018-08-03 | $267.63M 10-Q · filed 2019-07-31 | -$85.54M derived: sum of 3 quarters · filed 2020-02-25 | $50.56M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-03-31 | $111.95M 10-Q · filed 2019-05-03 | -$241.22M derived: sum of 2 quarters · filed 2020-02-25 | -$105.12M derived: sum of 3 quarters · filed 2020-02-25 | $26.70M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2017-12-31 | -$353.17M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$217.07M derived: sum of 2 quarters · filed 2020-02-25 | -$85.25M derived: sum of 3 quarters · filed 2020-02-25 | $20.31M 10-K · filed 2020-02-25 | ||
| 2017-09-30 | $136.10M 10-Q · filed 2018-11-02 | $267.93M derived: sum of 2 quarters · filed 2018-11-02 | $373.48M 10-Q · filed 2018-11-02 | |||
| 2017-07-01 | $131.82M 10-Q · filed 2018-08-03 | $237.38M 10-Q · filed 2018-08-03 | ||||
| 2017-04-01 | $105.56M 10-Q · filed 2018-05-04 | |||||
| 2016-12-31 | $521.50M 10-K/A · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| AGILENT TECHNOLOGIES, INC. (A) | United States | $48.720B | 27.14 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |